Protoporphyrin IX

Common Name

Protoporphyrin IX Description

Protoporphyrins are tetrapyrroles containing 4 methyl, 2 propionic and 2 vinyl side chains. Protopophyrin is produced by oxidation of the methylene bridge of protoporphyrinogen. Protoporphyrin IX is the only naturally occurring isomer; it is an intermediate in heme biosynthesis, combining with ferrous iron to form protoheme IX, the heme prosthetic group of hemoglobin. Protoporphyrin IX is created by the enzyme protoporphyrinogen oxidase. The enzyme ferrochelatase converts it into heme. Protoporphyrin IX naturally occurs in small amounts in feces. It is accumliated and excreted excessively in the feces in protoporphyria and variegate porphyria. Protoporphyrin IX is also responsible for the brown pigment (Ooporphyrin) of birds eggs Protoporphyrin IX is used as a branch point in the biosynthetic pathway leading to Heme (by insertion of iron) and chlorophylls (by insertion of Mg and further side-chain transformation). Protoporphyrin IX can be used to treat liver disorders, mainly as the sodium salt. Shows anti-HIV activity. Structure

Synonyms

Value Source 3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionic acidChEBI 3,7,12,17-Tetramethyl-8,13-divinylporphyrin-2,18-dipropanoic acidChEBI H2PpIXChEBI Kammerer's prophyrinChEBI OoporphyrinChEBI Porphyrinogen IXChEBI 3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionateGenerator 3,7,12,17-Tetramethyl-8,13-divinylporphyrin-2,18-dipropanoateGenerator 3,3'-(3,7,12,17-Tetramethyl-8,13-divinylporphine-2,18-diyl)diHMDB PpIXHMDB ProtoporphyrinHMDB Protoporphyrin-"ix"HMDB Protoporphyrin-IXHMDB

Chemical Formlia

C34H34N4O4 Average Molecliar Weight

562.6582 Monoisotopic Molecliar Weight

562.258005596 IUPAC Name

3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1(21),2,4,6,8(23),9,11,13,15,17,19-undecaen-4-yl]propanoic acid Traditional Name

protoporphyrin CAS Registry Number

553-12-8 SMILES

CC1=C(CCC(O)=O)/C2=C/C3=N/C(=CC4=C(C)C(C=C)=C(N4)/C=C4N=C(C=C1/N2)C(C=C)=C4C)/C(C)=C3CCC(O)=O

InChI Identifier

InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-

InChI Key

KSFOVUSSGSKXFI-UJJXFSCMSA-N Chemical Taxonomy Classification

Not classified Ontology Status

Detected and Quantified Origin

  • Endogenous
  • Biofunction

  • Component of Porphyrin and chlorophyll metabolism
  • Application

    Not Available Cellliar locations

  • Cytoplasm
  • Membrane (predicted from logP)
  • Mitochondria
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting Point300 °CNot Available Boiling PointNot AvailableNot Available Water Solubility0.169 mg/mL at 25 °CNot Available LogPNot AvailableNot Available

    Predicted Properties

    Property Value Source Water Solubility0.022 mg/mLALOGPS logP4.4ALOGPS logP6.78ChemAxon logS-4.4ALOGPS pKa (Strongest Acidic)3.68ChemAxon pKa (Strongest Basic)4.96ChemAxon Physiological Charge-2ChemAxon Hydrogen Acceptor Count6ChemAxon Hydrogen Donor Count4ChemAxon Polar Surface Area131.96 Å2ChemAxon Rotatable Bond Count8ChemAxon Refractivity163.81 m3·mol-1ChemAxon Polarizability65.97 Å3ChemAxon Number of Rings5ChemAxon Bioavailability0ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Not Available Biological Properties Cellliar Locations

  • Cytoplasm
  • Membrane (predicted from logP)
  • Mitochondria
  • Biofluid Locations

  • Blood
  • Tissue Location

  • Adipose Tissue
  • Adrenal Medlila
  • Bladder
  • Erythrocyte
  • Fibroblasts
  • Gastrointestinal Tract
  • Intestine
  • Kidney
  • Liver
  • Lymphocyte
  • Platelet
  • Skin
  • Spleen
  • Stratum Corneum
  • T-Lymphocyte
  • Testes
  • Thyroid Gland
  • Urinary Bladder
  • Pathways

    Name SMPDB Link KEGG Link Acute Intermittent PorphyriaSMP00344Not Available Congenital Erythropoietic Porphyria (CEP) or Gunther DiseaseSMP00345Not Available Hereditary Coproporphyria (HCP)SMP00342Not Available Porphyria Variegata (PV)SMP00346Not Available Porphyrin MetabolismSMP00024map00860

    Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodDetected and Quantified0.66 +/- 0.18 uMAdlit (>18 years old)FemaleNormal

  • Geigy Scientific …
  • details BloodDetected and Quantified0.53 +/- 0.13 uMAdlit (>18 years old)MaleNormal

  • Geigy Scientific …
  • details BloodDetected and Quantified1.09 +/- 0.57 uMNewborn (0-30 days old)BothNormal

  • Geigy Scientific …
  • details

    Abnormal Concentrations

    Not Available Associated Disorders and Diseases Disease References

    None Associated OMIM IDs

    None External Links DrugBank ID

    DB02285 DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB004277 KNApSAcK ID

    C00007370 Chemspider ID

    10469486 KEGG Compound ID

    C02191 BioCyc ID

    PROTOPORPHYRIN_IX BiGG ID

    39293 Wikipedia Link

    Protoporphyrin IX NuGOwiki Link

    HMDB00241 Metagene Link

    HMDB00241 METLIN ID

    4158 PubChem Compound

    Not Available PDB ID

    1HBG ChEBI ID

    15430

    Product: Saroglitazar (Magnesium)

    References Synthesis Reference Games, David E.; Jackson, Anthony H.; Jackson, J. Richard; Belcher, Roderick V.; Smith, Sydney G. Biosynthesis of protoporphyrin-IX from coproporphyrinogen-III. Journal of the Chemical Society, Chemical Communications (1976), (6), 187-8. Material Safety Data Sheet (MSDS) Download (PDF) General References
    1. Messmann H, Knuchel R, Baumler W, Holstege A, Scholmerich J: Endoscopic fluorescence detection of dysplasia in patients with Barretts esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc. 1999 Jan;49(1):97-101. [PubMed:9869731 ]
    2. Stankiewicz A, Lutz W, Krajewska B, Szulc B: [Plasma indicators of iron metabolism in persons occupationally exposed to organic solvents with normal and increased levels of protoporphyrin IX in erythrocytes]. Pol Tyg Lek. 1986 Jul 7;41(27):851-4. [PubMed:3763462 ]
    3. Stankiewicz A: [Erythrocyte protoporphyrin IX in occupational exposure to asbestos]. Med Pr. 1984;35(5):351-4. [PubMed:6530952 ]
    4. Sudworth CD, Stringer MR, Cruse-Sawyer JE, Brown SB: Fluorescence microspectroscopy technique for the study of intracellular protoporphyrin IX dynamics. Appl Spectrosc. 2003 Jun;57(6):682-8. [PubMed:14658702 ]
    5. Kufner G, Schlegel H, Jager R: A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes. Clin Chem Lab Med. 2005;43(2):183-91. [PubMed:15843214 ]
    6. Stankiewicz A: The concentration of protoporphyrin IX in workers occupationally exposed to lead. Mater Med Pol. 1989 Apr-Jun;21(2):100-2. [PubMed:2488459 ]
    7. Krieg RC, Fickweiler S, Wolfbeis OS, Knuechel R: Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol. 2000 Aug;72(2):226-33. [PubMed:10946577 ]
    8. Bailey GG, Needham LL: Simultaneous quantification of erythrocyte zinc protoporphyrin and protoporphyrin IX by liquid chromatography. Clin Chem. 1986 Dec;32(12):2137-42. [PubMed:3779978 ]
    9. Chisolm J Jr, Brown DH: Micro-scale photofluorometric determination of “free erythrocyte pophyrin” (protoporphyrin IX). Clin Chem. 1975 Oct;21(11):1669-82. [PubMed:1164799 ]
    10. Casas A, Batlle AM, Butler AR, Robertson D, Brown EH, MacRobert A, Riley PA: Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer. 1999 Jul;80(10):1525-32. [PubMed:10408393 ]
    11. Smits T, Robles CA, van Erp PE, van de Kerkhof PC, Gerritsen MJ: Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol. 2005 Oct;125(4):833-9. [PubMed:16185285 ]
    12. Bartosova J, Hrkal Z: Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA). Comp Biochem Physiol C Toxicol Pharmacol. 2000 Jul;126(3):245-52. [PubMed:11048674 ]
    13. Sakai T, Takeuchi Y, Ikeya Y, Araki T, Ushio K: [Automated HPLC method for determining zinc protoporphyrin IX and protoporphyrin IX in erythrocytes of workers exposed to lead]. Sangyo Igaku. 1988 Nov;30(6):467-74. [PubMed:3221502 ]
    14. Stankiewicz A, Lutz W, Szeszko A: [Protoporphyrin IX level in erythrocytes of persons with alcoholic liver cirrhosis]. Pol Tyg Lek. 1985 Jul 15;40(28):787-9. [PubMed:4059100 ]
    15. Star WM, Aalders MC, Sac A, Sterenborg HJ: Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or lontophoresis. Photochem Photobiol. 2002 Apr;75(4):424-32. [PubMed:12003134 ]
    16. von Beckerath M, Juzenas P, Ma LW, Iani V, Lofgren L, Moan J: The influence of UV exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin. Photochem Photobiol. 2001 Dec;74(6):825-8. [PubMed:11783939 ]
    17. Gottsch JD, Graham CR Jr, Hairston RJ, Chen CH, Green WR, Stark WJ: Protoporphyrin IX photosensitization of corneal endothelium. Arch Ophthalmol. 1989 Oct;107(10):1497-500. [PubMed:2803100 ]
    18. Bissonnette R, Zeng H, McLean DI, Korbelik M, Lui H: Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol. 2001 Aug;74(2):339-45. [PubMed:11547574 ]
    19. Rick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R: Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J Photochem Photobiol B. 1997 Oct;40(3):313-9. [PubMed:9372622 ]
    20. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MV: A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release. 2000 Apr 3;65(3):359-66. [PubMed:10699294 ]

    Enzymes

    General function:
    Involved in coproporphyrinogen oxidase activity
    Specific function:
    Key enzyme in heme biosynthesis. Catalyzes the oxidative decarboxylation of propionic acid side chains of rings A and B of coproporphyrinogen III.
    Gene Name:
    CPOX
    Uniprot ID:
    P36551
    Molecular weight:
    50151.605
    General function:
    Involved in catalytic activity
    Specific function:
    Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX.
    Gene Name:
    PPOX
    Uniprot ID:
    P50336
    Molecular weight:
    50764.8
    Reactions
    Protoporphyrinogen IX + Oxygen → Protoporphyrin IX + Hydrogen peroxide details Protoporphyrinogen IX + Oxygen → Protoporphyrin IX + Hydrogen peroxide details
    General function:
    Involved in ferrochelatase activity
    Specific function:
    Catalyzes the ferrous insertion into protoporphyrin IX.
    Gene Name:
    FECH
    Uniprot ID:
    P22830
    Molecular weight:
    47861.77
    Reactions
    Heme + Hydrogen Ion → Protoporphyrin IX + Fe2+ details Protoporphyrin IX + Fe2+ → Heme + Hydrogen Ion details
    General function:
    Involved in oxidoreductase activity
    Specific function:
    Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney
    Gene Name:
    FTL
    Uniprot ID:
    P02792
    Molecular weight:
    20019.5
    References
    1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
    2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
    3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235 ]
    General function:
    Involved in ferrochelatase activity
    Specific function:
    Catalyzes the ferrous insertion into protoporphyrin IX
    Gene Name:
    Not Available
    Uniprot ID:
    Q53FU1
    Molecular weight:
    47488.3
    General function:
    Involved in ferrochelatase activity
    Specific function:
    Catalyzes the ferrous insertion into protoporphyrin IX
    Gene Name:
    Not Available
    Uniprot ID:
    Q5TZY0
    Molecular weight:
    47680.5
    General function:
    Involved in ferrochelatase activity
    Specific function:
    Catalyzes the ferrous insertion into protoporphyrin IX
    Gene Name:
    DKFZp686P18130
    Uniprot ID:
    Q7KZA3
    Molecular weight:
    47131.9

    PMID: 26496941